RTTNews | Jan 11, 2021 04:55PM EST

16:54 Monday, January 11, 2021 (RTTNews.com) - Shares of GenMark Diagnostics Inc. (GNMK) gained over 7% on Monday after-hours after the molecular diagnostic testing systems maker issued a strong outlook for the fourth quarter and full year 2020.

For the full year 2020, total revenues is expected to be about $171 million, representing an increase of around 95% over 2019. ePlex revenues is expected to be around $152 million, an increase of 155% over 2019.

Revenues for the fourth quarter is expected to be around $50 million, representing an increase of 84% over the fourth quarter of 2019. ePlex revenues is expected to be about $45 million, an increase of 138% over the fourth quarter last year.

Analysts polled by Thomson Reuters currently estimate revenues of $45.87 million and $167.48 million for the fourth quarter and full year 2020, respectively.

Gross margin is expected to be approximately 39% for the fourth quarter and between 39% and 40% for the full year.

Read the original article on RTTNews ( https://www.rttnews.com/3159505/genmark-diagnostics-shares-up-7-on-revenue-outlook.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved